About About
Portfolio Portfolio
Investment Process Investment Process
People People
News News

REPAIR portfolio company LimmaTech Biologics expands vaccine pipeline by licensing AbVacc’s vaccine candidate against Staphylococcus aureus

The Novo Nordisk Foundation is commissioning the REPAIR Impact Fund initiative, and Novo Holdings is executing it.